Back to Results
First PageMeta Content



19 DecemberATL1102 for Multiple Sclerosis and Duchenne Muscular Dystrophy Update Antisense Therapeutics Limited (“ANP” or “the Company”) provides the following update on the progress of its Multiple Sclero
Add to Reading List

Document Date: 2018-02-11 19:58:19


Open Document

File Size: 46,58 KB

Share Result on Facebook